PDPL Stock Overview
Parenteral Drugs (India) Limited operates as a healthcare company in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Parenteral Drugs (India) Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹2.90 |
| 52 Week High | ₹4.25 |
| 52 Week Low | ₹2.70 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -34.83% |
| 3 Year Change | n/a |
| 5 Year Change | -66.28% |
| Change since IPO | -98.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| PDPL | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | 1.6% |
| 1Y | -34.8% | 35.7% | 17.5% |
Return vs Industry: PDPL underperformed the Indian Pharmaceuticals industry which returned 30.3% over the past year.
Return vs Market: PDPL underperformed the Indian Market which returned 19.4% over the past year.
Price Volatility
| PDPL volatility | |
|---|---|
| PDPL Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: PDPL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PDPL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | n/a | n/a | www.pdindia.com |
Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon.
Parenteral Drugs (India) Limited Fundamentals Summary
| PDPL fundamental statistics | |
|---|---|
| Market cap | ₹101.08m |
| Earnings (TTM) | -₹763.62m |
| Revenue (TTM) | ₹84.96m |
0.0x
P/S Ratio0.0x
P/E RatioIs PDPL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PDPL income statement (TTM) | |
|---|---|
| Revenue | ₹84.96m |
| Cost of Revenue | ₹54.66m |
| Gross Profit | ₹30.31m |
| Other Expenses | ₹793.93m |
| Earnings | -₹763.62m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did PDPL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/18 09:08 |
| End of Day Share Price | 2023/08/21 00:00 |
| Earnings | 2022/03/31 |
| Annual Earnings | 2022/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Parenteral Drugs (India) Limited is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|